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RESULTS OF TREATMENT OF BREAST CANCER IN SOUTH-EAST
ENGLAND
R. A. DIXON*
From the South Metropolitan Cancer Registry, Sutton, Surrey
THE results of treatment of groups of patients with primary malignant breast
tumours treated by individuals in single hospitals are published from time to
time. These all represent selection from the population with the disease and most
of them are published in order to support one treatment method or some com-
bination of treatment methods adopted by the person or institution involved.
Controlled clinical trials are overcoming many of the difficulties of comparison
created by these reports which must almost inevitably have their under-currents
oflocal pride. This report attempts to look at a fairly well defined population and
to see what happens to patients with breast cancer treated by many different
people using different combinations of treatment in different hospitals. No local
pride is involved; no treatment method is being advocated.
Morbidity of Breast Cancer
Between 1960 and 1962, during which regional registration ofmalignant disease
at the South Metropolitan Cancer Registry first became very nearly complete, an
annual average of3247 cases ofbreast cancer was reported among women actually
resident within the S.M.C.R. region. This corresponds to an annual registration
rate of 7-4 per 10,000 of the population, accounting for 25% of female cancer.
The annual age-specific registration rates of all cancer for each sex, and of female
breast cancer, during this period are shown in Fig. 1 (Payne and Dixon, 1966).
The influence of the menopause on the morbidity of breast cancer is apparent.
The age distributions of all cancer for each sex (Fig. 2) (Payne and Dixon, 1966)
illustrate the effect ofhigh breast cancer morbidity among women under 50 on the
age distribution of all female cancer during the period 1960-62.
The Series used to Determine Treatment and Survival
By the end of 1965, when this study began, 16,516 cases of primary breast
tumours in women, first diagnosed during the period 1958-62, had been reported
to the South Metropolitan Cancer Registry. Most of the patients were resident
in the Wessex, the South West Metropolitan or the South East Metropolitan
Hospital Boards' areas, although some (approximately 1200), attending hospitals
within this region, lived elsewhere. Since this study is concerned primarily with
survival rates up to five years after first treatment, and not with morbidity within
the region, patients resident outside the region were not excluded.
It was decided to group the 16,516 cases according to the clinical extent of
the disease, surgical treatment, radiotherapy, and age. (More than 20% of the
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patients underwent endocrine surgery or irradiation or received hormones or
chemotherapy but none of these factors was used to classify the patients.)
Regrettably, clinical staging of breast cancer at the hospitals where the patients
were first seen was not sufficiently widespread to permit more precise classification
than into " localised " and " non-localised " disease in a survey such as this.
Indeed, a proportion (8.8%°) had to be left completely unstaged. The criteria used
for separation into " localised " and " non-localised " were those adopted by
Lipworth (1965) and relate to detectable spread assessed by clinical examination
of the patients, in some cases assisted by radiological investigations. Those with
no spread beyond the breast tissue, no involvement of the axillary nodes, and no
metastases were considered to have localised disease. Skin involvement in direct
continuity with the tumour and not wide of it did not preclude the growth from
being considered as localised.
In terms of the well-known TNM classification recommended by the Inter-
national Union Against Cancer, non-localised disease was assumed to be present
if any one or more of the following condititions was satisfied:
Primary tumour T4
Regional lymph nodes Ni, N2 or N3
Distant metastases Ml
Where clinical considerations indicated that none of these was satisfied, localised
disease was assumed. The tumour was designated " unstaged " where insuffi-
cient information was recorded in the hospital case-notes. Methods of reducing
the number which could not be staged became apparent. For example, the few
patients upon whom radical mastectomies were performed and yet whose treat-
ments were described before-hand as palliative undoubtedly had advanced
disease.
Treatment
Fig. 3 shows how the broad treatment combinations were used in various age
groups, and Table I shows the use made of different surgery. 506% of all the
TABLE I.-Type ofSurgery Used in Various Age Groups: South
Metropolitan Cancer Registry (1958-62)
With surgery
_____________________________________________________ Totals with
Age Without Local Simple Radical Unspecified All or without
group surgery excision mastectomy mastectomy surgery surgery surgery
Age unknown. 22 . 1 10 28 7 46 . 68
Under 44 349 . 152 424 1127 210 1913 . 2262
45-54 . 730 . 176 761 1853 397 3187 . 3917
55-64 . 945 . 173 856 1584 360 2973 . 3918
Over 65 . 2444 . 288 1680 1435 504 3907 . 6351
All ages. 4490 . 790 3731 6027 1478 12026 . 16516
patients were treated by surgery and radiotherapy, and only 22.2% by surgery
alone. This is quite different from Lipworth's findings (1965) that " in some
regions of England and Wales surgery is at present used more frequently in the
treatment of breast cancer than surgery combined with radiation ". It has been
shown (Dixon, 1966) that this was not due to an influx ofpatients from other areas
in which radiotherapy facilities were less readily available. Those who are
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accustomed to hospital series may find the percentage of patients untreated by
surgery or radiotherapy (11%) rather high. However, this largely indicates the
percentage of patients registered eventually (perhaps from a death certificate) as
having had breast cancer, but who did not attend hospital.
Number of patients in each age group
3,917 3,918 6,351 68 16,516
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FIG. 3.-Broad types of treatment used in various age groups (South Metropolitan Cancer
Registry, 1958-62).
No surgery or radiotherapy.
e53 Surgery and radiotherapy.
Surgery only.
9 Radiotherapy only.
The term " unspecified surgery " applies to those patients for whom there was
not sufficient information to say whether the surgery given was local excision,
simple mastectomy or radical mastectomy. It refers only to treatment of the
primary tumour and does not include oophorectomy, adrenalectomy, hypo-
physectomy or removal of metastases. Although there is no intrinsic interest
in the survival rate of this category or indeed of those for whom the age or stage
were not known, they are nevertheless retained to contribute information to the
various sub-totals (e.g. over all ages) and to the grand total of all breast cancer
patients.
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Survival
Table I can be sub-divided according to whether or not radiotherapy was given,
and then according to the clinical stage categories " localised ", " non-localised "
or " unstaged ". Ultimately 504 different groupings of patients can be made in
this way for analysis of survival characteristics. Life-tablest (Greenwood, 1926)
were constructed from these groupings and showed for each of the first five years
the numbers alive, dead and untraced, the interval survival rate within that year
alone and the cumulative survival rate up to and including that year (and the
associated standard error). The cumulative one-, three-, and five-year survival
rates (with their standard errors) for some ofthe more interesting larger groups of
patients are given in Table II.
TABLE II.-Summary ofSurvival Ratesfor Some Large Groups ofPatients
Survival rates (with stan-
Number dard errors in parentheses)
of
Group cases
All patients . . . 16516
Localised disease . . . 5797
Non-localised disease . . 9271
Treated by surgery alone . . 3674
Treated by radiotherapy alone 2604
Treated by surgery and . 8352
radiotherapy
Treated by surgery with or . 12026
without radiotherapy
Not treated by surgery or . 1886
radiotherapy
Local excision with or . 790
without radiotherapy
Simple mastectomy with or . 3731
without radiotherapy
Radical mastectomy with or . 6027
without radiotherapy
Under 44 . . . . 2262
45-54 . . . . 3917
55-64 . . . . . 3918
Over 65 . . . 6351
AI
1 year 3 years 5 years
82-0 57-5 41-7
(0-3) (0-4) (0-5)
93 3 76-8 69-1
(0-3) (0 6) (0-7)
75-3 45 9 30-0
(0-5) (0-8) (0-6)
88-3
(0.5)
72-6
(O-9)
92-2
(0 3)
91-1
(0-3)
38-2
(11)
89-5
(1- 1)
89-7
(0 5)
92-6
(0 3)
90-7
(0 6)
87-8
(0-5)
83-6
(0-6)
74-3
(0-6)
69-9
(0 8)
37-3
(1 o0)
68-6
(0 6)
69-0
(0-5)
14-0
(0-8)
71-2
(1- 8)
63-2
(O-9)
72 - 1
(0 6)
69-0
(1-1)
65-2
(0 8)
58-9
(0 8)
47-5
(0 7)
55-5
(1-1)
20-1
(1*0)
51-9
(0 7)
53-0
(0-6)
4-7
(0-6)
55.5
(2 5)
46-1
(1-1) 55.4
(O 9)
55-2
(1 -4)
51-0
(1.0)
42-9
(1-0)
30-4
(0 8)
t This method uses information contributed by all patients up to the time when they become
untraced ", rather than excluding completely those who are lost sight ofat any stage, as is often done
to simplify the calculations. (A computer programme was written to construct the life-tables from
15 parameters for each of 262 selected groups out of the 504 possible groups, and to calculate the sur-
vival rates with their standard errors.) For this reason comparisons ofsurvival rates should be made
only within this paper and not with crude rates given elsewhere. However the rates given here are
not age-standardised for mortality from intercurrent diseases, although many are quoted for specific
age groups. Indeed these maybe ofmore practical interest since they represent the actual percentage
of patients in a particular age-group who can be expected to survive the stated period, and therefore
provide a realistic measure which can be considered in assessing the value ofmajor surgery.
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Fig. 4 shows the overall survival curve related to those for all localised, for
all non-localised, and for all unstaged patients, respectively. The very slightly
better curve for all patients than that for the unstaged alone suggests that the
patients left unstaged tended to have more advanced disease than the rest,
of whom 38% were clinically assessed as having localised disease. The overall
survival rate was 42%, and 50% ofthe patients survived 3 8 years or longer.
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FIG. 4.-Survival of patients grouped according to clinical assessment of advancement of
disease.
O O All patients (16,516).
* 0 Localised disease (5797 patients).
A/ A Non-localised disease (9271 patients).
A A Unstaged (1448 patients).
Fig. 6 illustrates the survival curves for different age groups. Corrections have
not been applied for deaths due to intercurrent diseases and these curves show how
the actual survival becomes progressively worse with advancing age.
Comparisons between survival after different methods of treatment must, of
course, be made cautiously because of the differing age- and stage-distributions
between them and because of all the factors considered in selecting a patient for a
particular treatment. Neither does an analysis such as this attempt to quantify
the quality ofsurvival. Ofall the groups ofpatients studied the highest five-year
survival rate (82 %) was found for patients under 44 years of age with localised
disease treated by radical mastectomy without radiotherapy. Fig. 6 shows the
survival curves for the broad treatment groups. The inflexion in the curve for
surgery with radiotherapy is ofinterest as is the closeness between this curve and
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that for surgery only. Fig. 7 shows these two groups separated into " localised"
and " non-localised". That the inflexion in those groups with radiotherapy as
well as surgeryis not an artefact is shown by the fact that it persists through all the
age, stage and type-of-surgery sub-groups as far as the statistical variations will
permit (not shown). It is in fact agraphical indication that for those patients who
were still alive in the third year (or thereabouts) the probability ofsurviving each
successive year actually increased thereafter for those treated by radiotherapy in
addition to surgery (Fig. 8). The survival curves displayed throughout this paper
are formed by plotting as a percentage the product of the probabilities (shown in
Fig. 8) ofsurvival to the endofeachyear for those who survived to the beginning of
it.
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FIG. 5.-Survival of four age groups.
O O Age 44 and under (2262 patients).
*- 0 Age 45-54 (3917 patients).
A A Age 55-64 (3918 patients).
A A Age 65 and over (6351 patients).
Consideration of the groups with various types of surgery with and without
radiotherapy respectively (Fig. 9-11) revealed that the radical mastectomy group
have worse survival (except for the first year) with radiotherapy than without, in
contrast to the finding for simple mastectomy and local excision. This is to be
expected since some of the patients with clinically localised disease who are
recommended for radical mastectomy proceed to have post-operative radiotherapy
as the result of surgical evidence (usually the discovery of hitherto unsuspected
involvement of the axillary nodes) of more advanced disease. The remaining
patients, including a high proportion with no involvement, have a better prognosis
since their disease is less advanced. Simple mastectomy patients show poor
survival (five year rate, all ages: 46 1%; standard error: I
- %) particularly those
with non-localised disease not also treated byradiotherapy (five year rate, all ages:
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28-3%; standard error: 3-1%). The absence of radiotherapy from local excision
and simple mastectomy inthe treatment ofadvancedbreast cancer mostfrequently
implies that only part of the disease has been treated, the intention to give post-
operative radiotherapy being frustrated by refusal to undergo further treatment
or because the local excision was performed only to prevent localfungation without
hope ofproducing a cure in a patient with generalised disease.
10)
0)
60
Years from first treatment
FIG. 6.-Survival of patients grouped according to broad treatment categories.
* 0 Surgery only (3674 patients).
O 0 Surgery and radiotherapy (8352 patients).
A A\ Radiotherapy only (2604 patients).
A A No surgery or radiotherapy (1886 patients).
An attempt was made to examine the suggestion by Lipworth (1965) that
"post-operative radiotherapy may not be suitable for female patients under 44
years with localised disease" as a result of his findings that this group (for
England and Wales, 1952-53) gave poorer survival-even before age correction,
reaching significance (P<O.05) after age correction-than the corresponding
45-54 age group. In the present survey, the survival rates have not been corrected
for the different mortality from intercurrent diseases according to the age dis-
tribution in the 262 groups considered. Nevertheless, the relevant data are
presented in Fig. 12-15 which compare in the two age groups the survival of
patients with localised disease treated by radiotherapy who have also had all
forms of surgery (Fig. 12), radical mastectomy (Fig. 13), simple mastectomy
(Fig. 14) and local excision (Fig. 15), respectively. Examination of these four
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diagrams together suggests that, although it is unlikely that the younger patients
(localised, surgery and radiotherapy) have a poorer survival after age correction
thanthe corresponding patients aged 45-54, radical mastectomy withradiotherapy
undoubtedly provides the least favourable survival comparison between the
respective age groups.
A possible explanation for this is that any tendency for a surgeon to treat a
higher proportion ofyounger patients with localised disease by radical mastectomy
as opposed to other (local) surgery would lead to an increase in the proportion of
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FIG. 7. FIG. 8.
FIG. 7.-Survival with and without radiotherapy.
O O Localised disease: surgery only (2031 patients).
* 0 Localised disease: surgery and radiotherapy (3231 patients).
A /A Non-localised disease: surgery only (1318 patients).
A A Non-localised disease: surgery and radiotherapy (4497 patients).
FIG. 8.-Percentage surviving each ofthe first five years ofthose alive at beginning ofeach year.
Surgery and radiotherapy (8352 patients).
---- Surgery only (3674 patients).
younger surgically treated patients (clinically assessed as having localised disease)
being given subsequent radiotherapy as a result of axillary lymph-node involve-
ment discovered only because the radical mastectomy was done. Such a situation
would, by selection, artificially cause a poorer survival in the younger patients with
localised disease treatedby surgery and radiotherapy than in those aged 45-54, but
a correspondingly better survival would appear for the younger patients with
localised disease treated by surgery alone than for those aged 45-54. This
corresponding improvement, however, was not found at a significant level by
Lipworth, and in the present survey, the proportions ill the two age groups treated
by radical mastectomy were identical (64% of all localised cases for whom the
type of surgery was known).
2
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FIG. 9.-Survival after local excision.
O O Local excision only (179 patients).
* 0 Local excision with radiotherapy (611 patients).
FIG. 10.-Survival after simple mastectomy.
O- O Simple mastectomy only (954 patients).
* 0 Simple mastectomy with radiotherapy (2777 patients).
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FTG. 11.-Survival after radical mastectomy.
O O Radical mastectomy only (1955 patients).
* 0 Radical mastectomy with radiotherapy (4072 patients).
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FI(w..12.--Survival of patients with localised disease after any surgery and radiotherapy.
* 0 Age 44 and under (577 patients).
O O Age 45-54 (933 patients).
FIG. 13. Survival of patients with localised disease after radical mastectomy and radiotherapy.
* 0 Age 44 and under (303 patients).
O O Age 45-54 (465 patients).
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FIG. 14. FIG. 15.
FIG. 14.-Survival of patients with localised disease after simple mastectomy and radiotherapy.
* 0- - Age 44 and under (158 patients).
O- O Age 45-54 (292 patients).
FIG. 15. Survival of patients with localised disease after local excision and radiotherapy.
*- 0 Age 44 and under (63 patients).
O O Age 45-54 (79 patients).
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It is apparent, from the point of view of the probability (if not the quality) of
survival, that the routine use of radiotherapy following radical mastectomy
requires some justification for pre-menopausal women with localised disease.
Regrettably it seems unlikely that a carefully controlled clinical trial could be
carried out on sufficient numbers to give a positive result in a reasonable length
of time.
SUMMARY
Between 1960-62 breast cancer accounted for 25% of all cancer in women in
South-East England, affecting younger women to a greater extent than other
cancer, the incidence rising steadily with increasing age with a minor peak in the
menopausal age-groups.
16,516 female breast cancer cases registered for 1958-62 were used to study
treatment and survival to five years. The age, stage and treatment distributions
are presented in this paper as well as the most interesting of 262 survival curves
plotted for various groups of patients. The highest five-year survival rate was
82Y. for patients under 44 years of age with localised disease treated by radical
mastectomy without radiotherapy. For all the patients considered, 42 %
survived five years and the median survival time was 3-8 years.
The effect of combined radiotherapy and surgery is discussed particularly
in pre- and post-menopausal patients with localised disease. The routine use of
radiotherapy with radical mastectomy for pre-menopausal women with localised
disease is questioned.
I wish to acknowledge the help of Professor D. W. Smithers (Department of
Radiotherapy, Royal Marsden Hospital) who suggested and encouraged this
study, Mr. P. M. Payne (South Metropolitan Cancer Registry) for advice through-
out, particularly on computer programming aspects, and Mr. B. L. Whitaker
(Department of Surgery, Royal Marsden Hospital) for commenting on the draft.
The South Metropolitan Cancer Registry's data is compiled through the
collaboration of all the hospitals who have permitted material to be registered,
and of all hospitals and general practitioners who have provided follow-up
information.
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